H19 and cancer: The pluripotent VSELs express variety of PGCs markers, and their number is increased in testicular pathologies (i.e., cancer), revealing reduced 5mC expression and altered Igf2-H19 (H19 imprinted maternally expressed transcript – insulin like growth factor 2) pattern and thus influencing the epigenetic profile [147–150].